26 Apr 2023
• Consolidated net profit was up 11.70% YoY at Rs 1,704.74 cr. • Revenue was up 11.96% YoY at Rs 8,929.23 cr. • Board has recommended a dividend of Rs 140/share.
• Glenmark Pharma will pay $87.5 mn to three plaintiff groups to settle multiple antitrust and consumer protection lawsuits in the US related to a generic drug.
• Consolidated net profit was up 23.46% YoY at Rs 268.59 cr. • Revenue was up 13.96% YoY at Rs 3,618.73 cr. • The numbers were better than expectations. • Board has recommended a final dividend of Rs 8.45/share.
Check More Details